LCLady Viviana Acosta Castillo

Lady Viviana Acosta Castillo

*This is an algorithmically generated author record based on publicly available information.

Lady Viviana Acosta Castillo has a total of 12 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    From Glycocalyx Shedding to Microvascular Collapse in Sepsis: Endothelial Pathophysiology, Organ Dysfunction, and Mechanistic Biomarkers

    by Jhan S. Saavedra-Torres, Lady Viviana Acosta Castillo, Alexandra Montoya Rendon, Daniel Esteban Castro Valencia, Diego A. Lucero Guanga, Manuela Garzon Ovalle, Fabián Darío Arias Rodríguez, Andrés López-Cortés, Juan S. Izquierdo-Condoy

    Sepsis is a systemic disorder in which infection-induced inflammation progressively disrupts vascular homeostasis and drives organ dysfunction. This review reframes septic pathophysiology as a sequential and self-amplifying process centered on endothelial failure. Early activation of innate immune pathways by pathogen- and damage-associated molecular patterns promotes cytokine release, oxidative stress, and enzymatic degradation of the endothelial glycocalyx. Loss of this protective surface layer exposes endothelial cells to unbuffered inflammatory and mechanical injury, impairing mechanotransduction, increasing leukocyte and platelet adhesion, and destabilizing vascular barrier function. Subsequent disruption of intercellular junctions promotes capillary leakage, tissue edema, and impaired oxygen diffusion, while mitochondrial dysfunction and redox imbalance reduce endothelial repair capacity. In parallel, complement activation, neutrophil extracellular trap formation, platelet–leukocyte interactions, and loss of anticoagulant signaling shift the microvasculature toward a prothrombotic and proinflammatory state. These interconnected mechanisms culminate in microvascular incoherence, characterized by heterogeneous capillary flow, regional hypoxia, impaired oxygen extraction, and progressive organ failure despite apparent restoration of systemic hemodynamics. Within this framework, biomarkers such as syndecan-1, soluble thrombomodulin, angiopoietin-2, von Willebrand factor, and plasminogen activator inhibitor-1 are best interpreted as mechanistic readouts of glycocalyx shedding, endothelial injury, permeability imbalance, and thromboinflammatory activation. Understanding sepsis as an evolving endothelial pathophysiological process provides a coherent framework for integrating inflammation, vascular leakage, hypoxia, coagulation, and organ dysfunction while identifying mechanistic biomarkers that reflect distinct stages of microvascular collapse.


  • Open Access

    Miopatía por micofenolato posterior a trasplante hepático: reporte de caso

    by Kevin Aníbal Lloreda-Aranzazú, Álvaro Andrés Montenegro-Apráez, Diego Mauricio Gómez-Ramírez, Mauricio Aragón-Delgado, Lady Viviana Acosta-Castillo

    Las miopatías inducidas por medicamentos son una causa relativamente frecuente de debilidad muscular aguda. En muchos casos, los síntomas comienzan poco después del inicio de la medicación causante; sin embargo, el diagnóstico puede ser difícil debido a la polifarmacia o a la asociación inicial de los síntomas con otras patologías. Esto puede provocar un retraso en la retirada del medicamento, lo cual es fundamental para el tratamiento. Se presenta el caso de un paciente de 62 años de edad con antecedentes de hepatocarcinoma, quien presentó debilidad muscular aguda en el posoperatorio de un trasplante hepático temprano. Se documentó una asociación excepcional con miopatía inducida por micofenolato. Tras suspender este fármaco, el paciente recuperó completamente la fuerza muscular, confirmando así el diagnóstico. De hecho, este caso es el segundo reportado en la literatura médica sobre miopatía inducida por micofenolato.